Bombesin, a bioactive peptide first identified in amphibian skin, is related to two mammalian peptides, gastrin-releasing peptide (GRP) and neuromedin B. A family of 3 GPCRs, including GRP-R (BB1), NMB-R (BB2) and BRS-3 (BB3), mediate the biological effects of the peptides. BB3 differs from the others by its low affinity for bombesin. Although an endogenous ligand for BB3 has yet to be identified, a synthetic nonselective bombesin-like peptide [D-Phe6, beta-Ala11, Phe13, Nle14]-bombesin-(6-14)-amide activates BB3 with high potency. BB3-null mice develop mild obesity that can be alleviated by treatment with an antiobesity compound, the serotonin and noradrenaline reuptake inhibitor Sibutramine.
Product Information | |
---|---|
Catalog #: | ACC-RG1252 |
Gene Name | BRS3 |
Abbr | CHO-HuBRS3/Apoaequorin |
Alias | BRS3,BRS-3 |
Growth Properties | Adherent |
Host Cell | CHO-K1 |
Morphology | Epithelial-like |
Shipping | Dry ice |
Product Type | GPCR Expressing Cell |
Species | Human |
Product Format | frozen |
searchKeyword | BRS3,BRS-3 |
Related Products
Catalog | Product Name | Gene Name | Species | Morphology | Price |
---|---|---|---|---|---|
ACC-RG1652 | Human BRS3 Stable Cell Line-CHO-K1 | BRS3 | Human | INQUIRY | |
ACC-RG0187 | Human BRS3-FLAG Stable Cell Line-HEK293T | BRS3 | Human | Epithelial | INQUIRY |
Inquiry